Delivery Order SPE2DB22D3501-SPE2DB25FXJ53
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,337.06 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count) on June 2, 2025, with completion scheduled for June 3, 2025. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, indicating competitive award. The product will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,950.76 for Candesartan Cilexetil 8 mg tablets (90-count) on September 2, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count) with a ceiling value of $102,998.84. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count) with a ceiling value of $2,175.48. This is a firm fixed-price delivery order with no set-aside designation, placing of performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 10, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count) with a ceiling value of $1,509.76. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a $60,591.71 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in quantities of 90, with completion expected by September 5, 2025. This is a firm fixed price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $10,879.54. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a ceiling value of $1,425.93. This firm fixed-price delivery order, which is expected to be completed by September 12, 2025, represents a non-competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count) with a ceiling value of $4,739.35. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,584.07 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count) on June 18, 2025, with completion scheduled for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXJ53Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a contract ceiling value of $6,090.09. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and established federal vendor that supplies a broad range of medications, vaccines, and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio of federal contract awards through the DLA demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains. As a critical vendor within the Defense Health Agency supply chain, AmerisourceBergen regularly receives delivery orders for both brand-name and generic medications to support ongoing military healthcare operations globally. The firm fixed-price structure and competitive award process reflect standard federal procurement practices for pharmaceutical commodity supplies through established contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 9/16/25 |